4.5 Review

Irisin: a new molecular marker and target in metabolic disorder

Journal

LIPIDS IN HEALTH AND DISEASE
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1476-511X-14-2

Keywords

Irisin; Obesity; Metabolic diseases

Funding

  1. Shanghai Shenkang Prevention Prog of Disease [SHDC12012303]
  2. Chinese Medical Association Fund [12020 550355]

Ask authors/readers for more resources

Irisin is a newly discovered exercise-mediated myokine which regulates energy metabolism and has been the subject of much recent research. Irisin plays an important role in metabolic diseases making it a potential new target to combat obesity and its associated disorders, such as T2DM. However, the results of several recent studies investigating the effects of irisin have been controversial. The present review will introduce the discovery of irisin, the role of irisin in metabolic disorders, possible mechanisms, and unanswered questions for future research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available